Cerebrovascular Events After Stentless Aortic Valve Replacement During a 9-Year Follow-Up Period

Annals of Thoracic Surgery

Volumn 86, Issue 3, 2008, Pages 769-773

  Gulbins, Helmut ^a   Florath, Ines ^a   Ennker, Juergen ^a  

^a Heart Institute Lahr   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; AORTA VALVE REPLACEMENT; ARTICLE; BYPASS SURGERY; CAROTID ARTERY DISEASE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RISK FACTOR; STROKE; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE; CAROTID ARTERY DISEASES; CEREBROVASCULAR DISORDERS; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; REGRESSION ANALYSIS; RISK FACTORS; STROKE;

EID: 49649102403     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.05.010     Document Type: Article

References (21)

1. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114 (2006) e84-e231
2. Mistiaen W., Van Cauwelaert P., Muylaert P., Sys S.U., Harrisson F., and Botier H. Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards Perimount pericardial prosthesis. J Thorac Cardiovasc Surg 127 (2004) 1166-1170
3. Wheatley D.J. The 'threshold age' in choosing biological versus mechanical prostheses in western countries. J Heart Valve Dis 13 Suppl (2004) S91-S94
4. Kaempchen S., Guenther T., Toschke M., Grunkemeier G.L., Wottke M., and Lange R. Assessing the benefit of biological valve prostheses: cumulative incidence (actual) vs. Kaplan-Meier (actuarial) analysis. Eur J Cardiothorac Surg 23 (2003) 710-713
5. Caradang R., Seshadri S., Beiser A., et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296 (2006) 2939-2946
6. Seshadri S., Beiser A., Kelly-Hayes M., et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 37 (2006) 345-350
7. Aupart M.R., Mirza A., Meurisse Y.A., Sirinelli A.L., Neville P.H., and Marchand M.A. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients. J Heart Valve Dis 15 (2006) 768-775
8. Ruel M., Masters R.G., Rubens F.D., et al. Late incidence and determinants of stroke after aortic and mitral valve replacement. Ann Thorac Surg 78 (2004) 77-83
9. Graf T., Reul H., Dietz W., Wilmes R., and Rau G. Cavitation of mechanical heart valves under physiologic conditions. J Heart Valve Dis 1 (1992) 131-141
10. Graf T., Reul H., Detlefs C., Wilmes R., and Rau G. Causes and formation of cavitation in mechanical heart valves. J Heart Valve Dis 3 Suppl (1994) S49-S64
11. Ennker J., Dalladaku F., Rosendahl U., Ennker I.C., Mauser M., and Florath I. The stentless freestyle bioprosthesis: impact of age over 80 years on quality of life, perioperative, and mid-term outcome. J Card Surg 21 (2006) 379-385
12. Dalal P.M., Mishra N.K., Battacherjee M., and Bhat P. Antithrombotic agents in cerebral ischemia. J Assoc Physicians India 54 (2006) 555-561
13. Shireman T.I., Mahnken J.D., Howard P.A., Kreskowik T.F., Hou Q., and Ellerbeck E.F. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest 130 (2006) 1390-1399
14. DiMarco J.P., Flaker G., Waldo A.L., et al. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 149 (2005) 650-656
15. Andersen K.K., and Olsen T.S. Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants: results from a Danish quality-control registry of 22,179 patients with ischemic stroke. Stroke 38 (2007) 259-263
16. Kakar P., and Lip G.Y. Atrial fibrillation and stroke prevention. Expert Rev Neurother 6 (2006) 1523-1530
17. Ngaage D.L., Schaff H.V., Mullany C.J., et al. Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting?. J Thorac Cardiovasc Surg 133 (2007) 182-189
18. Gulbins H., Kreuzer E., and Reichard B. Homografts: a review. Expert Rev Cardiovasc Ther 1 (2003) 533-539
19. O'Brien M.F., Harrocks S., Stafford E.G., et al. The homograft aortic valve: a 29-year, 99.3% follow-up of 1,022 valve replacements. J Heart Valve Dis 10 (2001) 334-344
20. Kappetein A.P., Puvimanasinghe J.P., Takkenberg J.J., Steyerberg E.W., and Bogers A.J. Predicted patient outcome after aortic valve replacement with Medtronic Stentless Freestyle bioprostheses. J Heart Valve Dis 16 (2007) 423-428
21. Deleuze P.H., Fromes Y., Khoury W., Maribas P., Lemaire S., and Bical O.M. Eight-year results of Freestyle stentless bioprosthesis in the aortic position: a single-center study of 500 patients. J Heart Valve Dis 15 (2006) 247-252